Picard Medical (PMI) Cash & Equivalents (2024 - 2026)

Picard Medical (PMI) has 3 years of Cash & Equivalents data on file, last reported at $121000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents changed N/A year-over-year to $121000.0; the trailing twelve-month figure through Mar 2026 stood at $121000.0 (changed N/A YoY), and the FY2025 full-year result was $7.5 million, up 7661.46% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $121000.0, down from $7.5 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $7.5 million in Q4 2025 and bottomed at $96000.0 in Q4 2024.
• The 3-year median for Cash & Equivalents is $410000.0 (2025), against an average of $2.2 million.
• Peak annual rise in Cash & Equivalents reached 7661.46% in 2025, while the deepest fall reached 7661.46% in 2025.
• A 3-year view of Cash & Equivalents shows it stood at $96000.0 in 2024, then jumped by 7661.46% to $7.5 million in 2025, then plunged by 98.38% to $121000.0 in 2026.
• The last three Cash & Equivalents figures came in at $121000.0 (Q1 2026), $7.5 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.

Peer Comparison